Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Metastatic Colon/Rectum Cancer|Non-squamous Non-small Cell Lung Cancer
Interventions: DRUG: [F-18]RGD-K5
Sponsor: Siemens Molecular Imaging